Abstract:Long non-coding RNAs (lncRNAs) are involved in controlling regulatory networks critical for gene expression, cellular growth, and development. Altered expression of lncRNAs are associated with tumor progression in multiple types of human cancers, but the mechanisms by which lncRNAs may control growth and proliferation in cancer cells remain unknown in most cases. Development of interventions targeting non-coding RNA regulation of cell growth would open new avenues for cancer treatment. To identify growth regulatory pathways controlled by non-coding RNAs, we used proteomics and genomics tools to study the effect of changes in lncRNA expression levels in human cancer cell lines. First, we identified five growth regulator lncRNAs based on data mining of CRISPR/Cas9 screens and high throughput sequencing studies from patient tumor and normal cells. These lncRNAs have been associated with progression and metastasis in breast, lung and colon cancers. We hypothesized that growth regulator lncRNAs play a role in cancer development by recruiting effector proteins to regulate gene expression. Next, we evaluated the cellular growth phenotype for each lncRNA in overexpression and knockdown strains using multiple established cancer cell lines. We analyzed cellular transcriptome changes after lncRNA perturbation using high-throughput RNA sequencing. Finally, RNA-protein interactions for each growth regulator lncRNA were identified using an RNA hybridization capture method paired with mass spectrometry that enables purification of direct and specific endogenous RNA-binding proteins. Using this combination of transcriptomics and proteomics data, we discovered that perturbation of growth regulator lncRNAs results in dysregulation of growth signaling pathways and increased expression of p53. We are currently identifying the sequence and structure determinants of RNA-protein complex formation to uncover the mechanisms of action of lncRNAs in controlling cancer cell growth. Citation Format: Tong Su, Bobby Kong, Calvin Huang, Jonathan Zhu, Colleen McHugh. Long non-coding RNA control of cancer cell growth [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl) nr 1533.

TTF1 control of LncRNA synthesis delineates a tumor suppressor pathway directly regulating the ribosomal RNA genes

TTF1 control of LncRNA synthesis and cell growth delineates a tumour suppressor pathway acting directly on the ribosomal RNA Genes

Identification of Curcumin As a Novel Natural Inhibitor of Rdna Transcription.

TIGAR promotes malignant proliferation of NSCLC by modulating deoxynucleotide anabolism via a YBX1-RRM2B axis

Autophagy Regulates Rrna Synthesis

Abstract 4770: The regulation of pre-ribosomal RNA synthesis by LKB1

The Regulation Of Pre-Ribosomal Rna Synthesis By Lkb1

A Transfer-Rna-derived Small RNA Regulates Ribosome Biogenesis.

Lncrna Mt1jp Functions As A Tumor Suppressor by Interacting with Tiar to Modulate the P53 Pathway

Abstract 1533: Long non-coding RNA control of cancer cell growth

Identification of a Long Non-Coding RNA-associated RNP Complex Regulating Metastasis at the Translational Step

Ribosomal RNA transcription governs splicing through ribosomal protein RPL22

A snoRNA-tRNA modification network governs codon-biased cellular states

TRF‐16 Inhibits Lung Cancer Progression by Hindering the N6‐Methyladenosine Modification of CPT1A mRNA

lncRNA TRMP-S directs dual mechanisms to regulate p27-mediated cellular senescence

PWP1 Mediates Nutrient-Dependent Growth Control Through Nucleolar Regulation of Ribosomal Gene Expression

Nucleoporin TPR Promotes Trna Nuclear Export and Protein Synthesis in Lung Cancer Cells.

SOX4-mediated Repression of Specific Trnas Inhibits Proliferation of Human Glioblastoma Cells.

The ribosomal protein L22 binds the pre-mRNA and promotes exon skipping to activate p53 upon nucleolar stress

hnRNP A1-mediated translational regulation of the G quadruplex-containing RON receptor tyrosine kinase mRNA linked to tumor progression

Lncrna Loc285194 Is A P53-Regulated Tumor Suppressor